Say what you want about Jeff Pearlman’s take on steroids in baseball, but at least he’s consistent. He was on Mike Silva’s NYBD podcast last night, and doubled down on his accusations:
For the record, Pearlman reiterated his position on Jeff Bagwell saying he was “so certain he used steroids from being around that team, era, and researching his Clemens book.” He would go on to tell me that if Bagwell didn’t use then the “world is flat.”When I asked him if Craig Biggio falls into the same category as Bagwell because he played for Houston, a team that he said earlier in the show was hotbed for PED use, he said yes.
At this point Pearlman is so far out on an accusatory limb that the notion of holding back for fear of a lawsuit or something is silly. As such — and given how important he and so many others view the issue of steroids to baseball and the Hall of Fame — is he not obligated to actually report on it? To pass along the information he gleaned from his research for his Clemens book which he says implicates Bagwell and Biggio?
This isn’t a rhetorical question. There’s so much irresponsible speculation floating around. Pearlman clearly believes that it’s not a point of speculation: it’s fact. And Pearlman may be right about this stuff. Doesn’t he do baseball journalism a service by settling the matter? If I was a Sports Illustrated editor I’d be calling him ten times a day, imploring him to write the story.
According to FanRag Sports’ Jon Heyman, free agent reliever Joba Chamberlain has a deal with the Brewers. No confirmation or terms of the contract have been confirmed by the team yet.
Chamberlain, 31, had a promising resurgence in the Indians’ bullpen during 2016. He shaved his ERA down to a modest 2.25 mark over 20 innings with Cleveland, paired with an 8.1 SO/9 and less-than-stellar 5.0 BB/9 rate. Over a decade in the major leagues, the right-hander holds a career 3.81 ERA, 8.8 SO/9 and 3.7 BB/9 rate.
The veteran righty was released by the Indians in July after refusing re-assignment. He’s expected to compete for a major league role this spring.
After letting rumors of the deal percolate for the last week, the Athletics officially announced their two-year, $11 million contract with right-hander Santiago Casilla on Friday (and threw a little bit of shade at the Giants, too). As previously reported, the contract includes an extra $3 million in performance bonuses.
Casilla, 36, got his major league start with Oakland back in 2004, racking up a 5.11 ERA and four saves over six seasons in the A’s bullpen. After picking up a minor league deal with the Giants in 2010, the righty flitted in and out of the closing role with varying degrees of success. Notwithstanding a slight downturn in his production rate during the 2016 season, he earned 123 saves and a 2.42 ERA during the past seven years in San Francisco. Securing another closing role might be a little tougher across the Bay, however, with a bullpen that includes fellow closers Ryan Madson, Ryan Dull and Sean Doolittle.